Wave Life Sciences (WVE) Return on Invested Capital (2016 - 2024)
Wave Life Sciences (WVE) has disclosed Return on Invested Capital for 10 consecutive years, with 2.2% as the latest value for Q3 2024.
- For the quarter ending Q3 2024, Return on Invested Capital fell 422.0% year-over-year to 2.2%, compared with a TTM value of 2.2% through Sep 2024, down 422.0%, and an annual FY2023 reading of 24.61%, down 134.0% over the prior year.
- Return on Invested Capital was 2.2% for Q3 2024 at Wave Life Sciences, up from 7.57% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 157.08% in Q4 2023 and bottomed at 11.73% in Q3 2022.
- Average Return on Invested Capital over 5 years is 7.32%, with a median of 2.2% recorded in 2024.
- The sharpest move saw Return on Invested Capital soared 15050bps in 2023, then plummeted -1074bps in 2024.
- Year by year, Return on Invested Capital stood at 1.6% in 2020, then crashed by -155bps to 4.06% in 2021, then surged by 262bps to 6.59% in 2022, then surged by 2285bps to 157.08% in 2023, then tumbled by -101bps to 2.2% in 2024.
- Business Quant data shows Return on Invested Capital for WVE at 2.2% in Q3 2024, 7.57% in Q2 2024, and 2.2% in Q1 2024.